
RCUS
Arcus Biosciences Inc.
$12.52
+$0.13(+1.05%)
36
Overall
--
Value
36
Tech
--
Quality
Market Cap
$1.32B
Volume
919.99K
52W Range
$6.50 - $18.98
Target Price
$29.09
Order:
Income Statement
Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||
Total Revenue | $8.4M | $15.0M | $77.5M | $383.0M | $112.0M | $117.0M | $258.0M | ||
Total Revenue | $8.4M | $15.0M | $77.5M | $383.0M | $112.0M | $117.0M | $258.0M | ||
COST OF GOODS SOLD | |||||||||
Cost of Revenue | -- | -- | $3.8M | -- | -- | -- | -- | ||
GROSS PROFIT | |||||||||
Gross Profit | $8.4M | $15.0M | $77.5M | $383.0M | $112.0M | $117.0M | $258.0M | ||
OPERATING EXPENSES | |||||||||
Operating Expenses | $-63.2M | $103.7M | $201.8M | $329.0M | $392.0M | $457.0M | $588.0M | ||
Research & Development | $49.6M | $78.5M | $159.3M | $257.0M | $288.0M | $340.0M | $448.0M | ||
Research Expense | $49.6M | $78.5M | $159.3M | $257.0M | $288.0M | $340.0M | $448.0M | ||
Selling, General & Administrative | $13.6M | $25.2M | $42.4M | $72.0M | $104.0M | $117.0M | $120.0M | ||
General & Administrative Expenses | $13.6M | $25.2M | $42.4M | $72.0M | $104.0M | $117.0M | $120.0M | ||
Salaries & Wages | -- | -- | -- | -- | $65.0M | $73.0M | $76.0M | ||
Depreciation & Amortization | $-3.7M | -- | -- | -- | -- | -- | -- | ||
Depreciation & Amortization | $-3.7M | -- | -- | -- | -- | -- | -- | ||
Amortization | -- | -- | -- | -- | -- | $1.0M | $3.0M | ||
Other Operating Expenses | $-63.2M | $-1.1M | $-1.2M | $-2.0M | $-3.0M | $-3.0M | $-5.0M | ||
OPERATING INCOME | |||||||||
Operating income | $-54.9M | $-88.7M | $-124.2M | $54.0M | $-280.0M | $-340.0M | $-330.0M | ||
EBITDA | $-47.7M | $-83.8M | $-120.0M | $59.0M | $-250.0M | $-285.0M | $-263.0M | ||
NON-OPERATING ITEMS | |||||||||
Interest Expense (Non-Operating) | -- | -- | -- | -- | $2.0M | $2.0M | $2.0M | ||
Intinc | $4.9M | -- | $1.4M | -- | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | $4.9M | -- | $1.4M | -- | $-14.0M | $-39.0M | $-2.0M | ||
Gain on Sale of Securities | -- | -- | $613.0K | -- | -- | -- | -- | ||
Other Income/Expense | $-343.0K | $-4.0M | $-1.4M | $-1.0M | -- | $-108.0M | $20.0M | ||
Other Special Charges | -- | $5.2M | $1.4M | $1.0M | -- | $108.0M | $243.0M | ||
SPECIAL ITEMS | |||||||||
Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $20.0M | ||
PRE-TAX INCOME | |||||||||
EBIT | $-49.6M | $-84.7M | $-123.0M | $55.0M | $-264.0M | $-301.0M | $-280.0M | ||
Pre-Tax Income | $-49.6M | $-84.7M | $-122.9M | $55.0M | $-266.0M | $-301.0M | $-282.0M | ||
INCOME TAX | |||||||||
Tax Provision | -- | -- | -- | $2.0M | $1.0M | $6.0M | $1.0M | ||
NET INCOME | |||||||||
Net Income | $-49.6M | $-84.7M | $-123.0M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
Net Income (Continuing Operations) | $-49.6M | $-84.7M | $-122.9M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
Net Income (Discontinued Operations) | $-49.6M | $-84.7M | $-123.0M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
Net Income (Common Stockholders) | $-49.6M | $-84.7M | $-123.0M | $53.0M | $-267.0M | $-307.0M | $-283.0M | ||
TOTALS | |||||||||
Total Expenses | $-63.2M | $103.7M | $205.5M | $329.0M | $392.0M | $457.0M | $588.0M | ||
SHARE & EPS DATA | |||||||||
Average Shares Outstanding | $34.6M | $43.8M | $54.8M | $69.3M | $72.0M | $74.0M | $90.1M | ||
Average Shares Outstanding (Diluted) | $34.7M | $43.8M | $63.5M | $74.0M | $72.0M | $74.0M | $90.1M | ||
Shares Outstanding | $44.5M | $46.0M | $70.9M | $71.1M | $73.0M | $90.9M | $105.8M | ||
Basic EPS | -- | $-1.93 | -- | $0.76 | $-3.71 | $-4.15 | $-3.14 | ||
Basic EPS (Continuing Operations) | -- | $-1.93 | $-0.82 | $0.76 | $-3.71 | $-4.15 | $-3.14 | ||
Diluted EPS | $-1.43 | $-1.93 | $-2.24 | $0.71 | $-3.71 | $-4.15 | $-3.14 | ||
Diluted EPS (Continuing Operations) | -- | -- | $-0.82 | $0.71 | $-3.71 | $-4.15 | $-3.14 | ||
OTHER METRICS | |||||||||
Earnings from equity interest | $343.0K | $-1.2M | $-613.0K | -- | -- | -- | -- | ||
Earnings From Equity Interest Net Of Tax | $343.0K | $-1.2M | $-613.0K | -- | -- | -- | -- | ||
Other Gand A | $13.6M | $25.2M | $42.4M | $72.0M | $104.0M | $117.0M | $120.0M | ||
Rent And Landing Fees | $13.6M | $1.6M | $42.4M | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | RCUS | $12.52 | +1.0% | 919.99K |
3 | ||||
4 | ||||
5 | ||||
6 |